Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) Return on Sales (2024 - 2025)

Allarity Therapeutics' Return on Sales history spans 2 years, with the latest figure at 38.92% for Q4 2025.

  • For Q4 2025, Return on Sales rose 8006.0% year-over-year to 38.92%; the TTM value through Dec 2025 reached 29.89%, up 1743.0%, while the annual FY2025 figure was 17.38%, N/A changed from the prior year.
  • Return on Sales reached 38.92% in Q4 2025 per ALLR's latest filing, down from 49.23% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 231.8% in Q3 2024 to a low of 118.97% in Q4 2024.